CELF1 and acute myeloid leukemia: Our findings provide new insights into the potential mechanisms of AML chemotherapy resistance, which will help clarify the precise regulatory mechanisms of AML chemotherapy resistance and offer a new perspective on CELF1 and other RBPs as novel therapeutic targets for AML.